Advances in Gestational Diabetes

Gestational diabetes also known as gestational diabetes mellitus (GDM), is a condition in which women without previously diagnosed diabetes exhibit high blood glucose (blood sugar) levels during pregnancy (especially during their third trimester). Gestational diabetes is caused by improper insulin responses. This is likely due to pregnancy-related factors such as the presence of human placental lactogen that interferes with susceptible insulin receptors, which in turn causes inappropriately elevated blood sugar levels. Gestational diabetes affects 3–10% of pregnancies, depending on the population studied. Typically gestational diabetes will disappear after the baby is born. As with diabetes mellitus in pregnancy in general, babies born to mothers with untreated gestational diabetes are typically at increased risk of problems such as being large for gestational age, which may lead to delivery complications, low blood sugar, and jaundice. If untreated, it can also cause seizures or stillbirth. Gestational diabetes is a treatable condition and women who have adequate control of glucose levels can effectively decrease these risks.

 

In the present book, fourteen typical literatures about gestational diabetes published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, hemadenology, gynecology ect. We hope this book can demonstrate advances in gestational diabetes as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    The Role of Gestational Diabetes, Pre-Pregnancy Body Mass Index and Gestational Weight Gain on the Risk of Newborn Macrosomia: Results from a Prospective Multicentre Study
  • Chapter 2
    Long-Term Changes in Glucose Metabolism after Gestational Diabetes: A Double Cohort Study
  • Chapter 3
    Quantification of the Type 2 Diabetes Risk in Women with Gestational Diabetes: A Systematic Review and Meta-Analysis of 95,750 Women
  • Chapter 4
    Progression from Gestational Diabetes to Type 2 Diabetes in One Region of Scotland: An Observational Follow-Up Study
  • Chapter 5
    The Forgotten Risk? A Systematic Review of the Effect of Reminder Systems for Postpartum Screening for Type 2 Diabetes in Women with Previous Gestational Diabetes
  • Chapter 6
    The DIAMIND Study: Postpartum SMS Reminders to Women Who Have Had Gestational Diabetes Mellitus to Test for Type 2 Diabetes: A Randomised Controlled Trial – Study Protocol
  • Chapter 7
    Early Cardiovascular Events in Women with a History of Gestational Diabetes Mellitus
  • Chapter 8
    Primary Prevention of Gestational Diabetes for Women Who Are Overweight and Obese: A Randomised Controlled Trial
  • Chapter 9
    A Pragmatic Cluster Randomized Clinical Trial of Diabetes Prevention Strategies for Women with Gestational Diabetes: Design and Rationale of the Gestational Diabetes’ Effects on Moms (GEM) Study
  • Chapter 10
    A Randomised Translational Trial of Lifestyle Intervention Using a 3-Tier Shared Care Approach on Pregnancy Outcomes in Chinese Women with Gestational Diabetes Mellitus but Without Diabetes
  • Chapter 11
    An Evaluation of Croí MyAction Community Lifestyle Modification Programme Compared to Standard Care to Reduce Progression to Diabetes/Pre-Diabetes in Women with Prior Gestational Diabetes Mellitus (GDM): Study Protocol for a Randomised Controlled Trial
  • Chapter 12
    Exercise Intervention during Pregnancy Can Be Used to Manage Weight Gain and Improve Pregnancy Outcomes in Women with Gestational Diabetes Mellitus
  • Chapter 13
    The Relationship between Low Maternal Serum Vitamin D Levels and Glycemic Control in Gestational Diabetes Assessed by HbA1c Levels: An Observational Cross-Sectional Study
  • Chapter 14
    Mothers after Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) Post-Natal Intervention: Study Protocol for a Randomized Controlled Trial
Readership: Students, academics, teachers and other people attending or interested in Advances in Gestational Diabetes
Salvatore Alberico
Department of Obstetrics and Gynaecology, Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, via dell’Istria 65/1,Trieste, Italy

Girish Rayanagoudar
Women’s Health Research Unit, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, UK

Claire E. Eades
School of Health Sciences, University of Stirling, Stirling, UK

Emer Heatley
Australian Research Centre for Health of Women and Babies, Robinson Institute, The University of Adelaide, King William Road North, Adelaide, Australia

Karine Goueslard
Service de Biostatistique et d’Informatique Médicale (DIM), Université de Bourgogne, Dijon, France

Assiamira Ferrara
Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, USA

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top